Bladder Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People whose doctors estimate they have a life expectancy of 10 years or more based on their biological age
- People who have not previously had any prostate treatments, such as laser surgery, TURP (a procedure to clear a blocked urethra), or focal therapy (targeted tumour treatment)
- People who have not had radiation therapy to the pelvis or prostate
- People who have not had previous surgery on the abdomen or rectum
- People who have not had hormone therapy (androgen-deprivation therapy) to reduce testosterone before this point
- People who have not had a stroke or reduced blood flow to the brain that left lasting neurological effects
- People who do not have a neurological condition such as Parkinson's disease
- People who have had a prostate biopsy taking at least 12 samples from both sides of the prostate, using MRI-guided and systematic methods
- People whose PSA blood test result is 15 ng/mL or below, and whose prostate is 80 mL in size or smaller
- People whose biopsy results show a cancer grade in the ISUP 1–3 range (also described as Gleason scores 3+3, 3+4, or 4+3)
- People whose biopsy does not show certain more aggressive cancer patterns (specifically Gleason pattern 5, intraductal, cribriform, or neuroendocrine carcinoma)
- People who have had a specific type of prostate MRI scan (required if the biopsy Gleason score is 3+4 or higher)
- People whose staging investigations show no signs that the cancer has spread to other parts of the body
Who may not be able to join:
- People who do not meet any one of the inclusion criteria listed above
- People who decline the trial procedure and instead choose to proceed with the standard robotic-assisted surgery as recommended under European urology guidelines
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Technical feasibility of ToP-RAP; Perioperative safety (Clavien-Dindo); Time to urinary continence recovery
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.